Homocysteine in small-for-gestational age and appropriate-for-gestational age preterm neonates from mothers receiving folic acid supplementation

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 8, 2010, Pages 1157-1161

  Gomes, Thushari S ^a   Lindner, Ulrike ^a   Tennekoon, Kamani H ^b   Karandagoda, Wimal ^c   Gortner, Ludwig ^a   Obeid, Rima ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOMBO   (Sri Lanka)

^c Castle Street Hospital for Women ^*  (Sri Lanka)

Author keywords

appropriate for gestational age; folic acid supplementation; homocysteine; methylenetetrahydrofolate reductase polymorphism; small for gestational age

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD ANALYSIS; BODY MASS; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PREGNANT WOMAN; PREMATURITY; PRENATAL PERIOD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SMALL FOR DATE INFANT; UMBILICAL CORD BLOOD; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; BIRTH WEIGHT; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; FOLIC ACID; FOLIC ACID DEFICIENCY; GESTATIONAL AGE; HOMOCYSTEINE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MOTHERS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREMATURE BIRTH; VITAMIN B 12;

EID: 77955464547     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.235     Document Type: Article

References (47)

1. Wardlaw TM, Blanc AK, Zupan J, Å hman E, compilers. Low birthweight: country, regional and global estimates. United Nations Children's Fund (UNICEF), World Health Organization (WHO), editors. Geneva, New York: WHO wDepartment of Reproductive Health and Researchx, UNICEF wStrategic Information Unit, Division of Policy and Planningx, 2004:ii,27pp.
2. Abeysena C, Jayawardana P, de A Seneviratne R. Maternal sleep deprivation is a risk factor for small for gestational age: a cohort study. Aust N Z J Obstet Gynaecol 2009;49:382-387
3. Senanayake MP, Gunawardene MK. Neonatal morbidity following control of maternal diabetes with human insulin. Sri Lanka J Child Health 2000;29:11-14
4. Amarasena S. Guidelines for the use of surfactant in Sri Lanka wLetterx. Sri Lanka J Child Health 2008;37:103-104
5. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000;182:198-206.
6. Reiss I, Landmann E, Heckmann M, Misselwitz B, Gortner L. Increased risk of bronchopulmonary dysplasia and increased mortality in very preterm infants being small for gestational age. Arch Gynecol Obstet 2003;269:40-44
7. Baschat AA. Fetal responses to placental insufficiency: An update. Br J Obstet Gynaecol 2004;111:1031-1041
8. Villar J, Altobelli L, Kestler E, Beliźan J. A health priority for developing countries: The prevention of chronic fetal malnutrition. Bull World Health Organ 1986;64:847-851
9. Lindblad B, Zaman S, Malik A, Martin H, Ekström AM, Amu S, et. al. Folate, vitamin B12, and homocysteine levels in South Asian women with growth-retarded fetuses. Acta Obstet Gynecol Scand 2005;84:1055-1061
10. van Beynum IM, Kapusta L, den Heijer M, Vermeulen SH, Kouwenberg M, Daniëls O, et. al. Maternal MTHFR 677C)T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 2006;27:981-987
11. Timmermans S, Jaddoe VW, Hofman A, Steegers-Theunissen RP, Steegers EA. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: The Generation R Study. Br J Nutr 2009;102:777-785
12. Refsum H, Nurk E, Smith AD, Ueland PM, Gjesdal CG, Bjelland I, et. al. The Hordaland Homocysteine Study: a community- based study of homocysteine. Its determinants, and associations with disease. J Nutr 2006;136:1731S-40S.
13. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing H, et. al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: The Hordaland Homocysteine Study. Am J Clin Nutr 2000;71:962-968
14. Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000;72:324-332
15. Boers GJ. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance. Thromb Haemost 1997;78:520-522
16. Brattström L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 2000;72:315-323
17. Hongsprabhas P, Saboohi F, Aranda JV, Bardin CL, Kovacs LB, Papageorgiou AN, et. al. Plasma homocysteine concentrations of preterm infants. Biol Neonate 1999;76:65-71.
18. Murphy MM, Scott JM, Arija V, Molloy AM, Fernandez-Ballart JD. Maternal homocysteine before conception and throughout pregnancy predicts fetal homocysteine and birth weight. Clin Chem 2004;50:1406-1412
19. Obeid R, Munz W, Jäger M, Schmidt W, Herrmann W. Biochemical indexes of the B vitamins in cord serum are predicted by maternal B vitamin status. Am J Clin Nutr 2005;82:133-139
20. Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ 1987; 65:663-737.
21. Amouzou EK, Chabi NW, Adjalla CE, Rodriguez-Guéant RM, Feillet F, Villaume C, et. al. High prevalence of hyperhomocysteinemia related to folate deficiency and the 677C™T mutation of the gene encoding methylenetetrahydrofolate reductase in coastal West Africa. Am J Clin Nutr 2004;79:619-624
22. Caudill MA, Le T, Moonie SA, Esfahani ST, Cogger EA. Folate status in women of childbearing age residing in Southern California after folic acid fortification. J Am Coll Nutr 2001;20: 129-134
23. Monsen A-LB, Ueland PM, Vollset SE, Guttormsen AB, Solheim E, Refsum H, et. al. Determinants of cobalamin status in newborns. Pediatrics 2001;108:624-630
24. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications wReviewx. Clin Chem 1993;39:1764-1779
25. Xu W-H, Shrubsole MJ, Xiang Y-B, Cai Q, Zhao G-M, Ruan Z-X, et. al. Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2007;16:281-287
26. Rosen MP, Shen S, McCulloch CE, Rinaudo PF, Cedars MI, Dobson AT. Methylenetetrahydrofolate reductase (MTHFR) is associated with ovarian follicular activity. Fertil Steril 2007;88: 632-638
27. Guerra-Shinohara EM, Morita OE, Peres S, Pagliusi RA, Sampaio Neto LF, d'Almeida V, et. al. Low ratio of S-adenosylmethionine to S-adenosylhomocysteine is associated with vitamin deficiency in Brazilian pregnant women and newborns. Am J Clin Nutr 2004;80:1312-1321
28. Molloy AM, Mills JL, McPartlin J, Kirke PN, Scott JM, Daly S. Maternal and fetal plasma homocysteine concentrations at birth: The influence of folate, vitamin B12, and the 5,10-methylenetetrahydrofolate reductase 677C™T variant. Am J Obstet Gynecol 2002;186:499-503.
29. Obeid R, Schorr H, Eckert R, Herrmann W. Vitamin B12 status in the elderly as judged by available biochemical markers. wTechnical briefx. Clin Chem 2004;50:238-241
30. Kramer MS, Goulet L, Lydon J, Séguin L, McNamara H, Dassa C, et. al. Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol 2001; 15:104-123
31. Leeda M, Riyazi N, de Vries JI, Jakobs C, van Geijn HP, Dekker GA. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 1998;179:135-139
32. Takimoto H, Mito N, Umegaki K, Ishiwaki A, Kusama K, Abe S, et. al. Relationship between dietary folate intakes, maternal plasma total homocysteine and B-vitamins during pregnancy and fetal growth in Japan. Eur J Nutr 2007;46:300-306
33. Infante-Rivard C, Rivard G-E, Gauthier R, Théorêt Y. Unexpected relationship between plasma homocysteine and intrauterine growth restriction. Clin Chem 2003;49:1476-1482
34. Yasuda S, Hasui S, Yamamoto C, Yoshioka C, Kobayashi M, Itagaki S, et. al. Placental folate transport during pregnancy. Biosci Biotechnol Biochem 2008;72:2277-2284
35. Bisseling TM, Steegers EA, van den Heuvel JJ, Siero HLM, van de Water FM, Walker AJ, et. al. Placental folate transport and binding are not impaired in pregnancies complicated by fetal growth restriction. Placenta 2004;25:588-593
36. Quadros EV, Nakayama Y, Sequeira JM. The protein and the gene encoding the receptor for the cellular uptake of transcobalamin- bound cobalamin. Blood 2009;113:186-192
37. Tsitsiou E, Sibley CP, d'Souza SW, Catanescu O, Jacobsen DW, Glazier JD. Homocysteine transport by systems L, A and yqL across the microvillous plasma membrane of human placenta. J Physiol (London) 2009;587:4001-4013
38. Malinow MR, Rajkovic A, Duell PB, Hess DL, Upson B. The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst( e)ine in fetal metabolism. Am J Obstet Gynecol 1998;178: 228-233
39. Gunasekera PC, Chandrasena LG, Gunasekera DP, Sirisena J. Time we increased folic acid consumption in Sri Lanka. Ceylon Med J 1997;42:159-163
40. Baumslag N, Edelstein T, Metz J. Reduction of incidence of prematurity by folic acid supplementation in pregnancy. Br Med J 1970;1:16-17
41. Ceesay SM, Prentice AM, Cole TJ, Foord FA, Weaver LT, Poskitt EM, et. al. Effects on birth weight and perinatal mortality of maternal dietary supplements in rural gambia: 5 year randomized controlled trial. Br Med J 1997;315:786-790
42. Markan S, Sachdeva M, Sehrawat BS, Kumari S, Jain S, Khullar M. MTHFR 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertensions in Indians. Mol Cell Biol 2007;302:125-131
43. Sood SK, Ramachandran K, Mathur M, Gupta K, Ramalingaswamy V, Swarnabai C, et. al. W.H.O. Sponsored Collaborative Studies on Nutritional Anaemia in India: 1. The effects of supplemental oral iron administration to pregnant women. Q J Med 1975;44:241-258
44. Koren G, Goh YI, Klieger C. Folic acid: The right dose. wMotherrisk updatex. Can Fam Physician 2008;54:1545-1547
45. Goh YI, Koren G. Folic acid in pregnancy and fetal outcomes. J Obstet Gynaecol 2008;28:3-13.
46. Wald NJ, Law MR, Wald DS. Quantifying the effect of folic acid. Lancet 2001;358:2069-2073
47. Wald DS, Morris JK, Law M, Wald NJ. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. Br Med J 2006;333:1114-1117